13F

IRMD IRADIMED CORP

2026Q1 · CUSIP 46266A109 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over
Holders
225
Δ holders QoQ
+10
Breadth percentile
Top 29%
Whale holders
113
Δ whales
+7
Inst. holding value
$730M
New positions
34
Closed positions
24
Price momentum (1Q)
-11.7%
Put / Call
2/2

Breadth history (34 quarters)

2018Q1: Δ-1 · h=36 2018Q2: Δ+15 · h=51 2018Q3: Δ+19 · h=70 2018Q4: Δ-3 · h=67 2019Q1: Δ-3 · h=64 2019Q2: Δ-9 · h=55 2019Q3: Δ+5 · h=60 2019Q4: Δ+5 · h=65 2020Q1: Δ+5 · h=70 2020Q2: Δ-5 · h=65 2020Q3: Δ-3 · h=62 2020Q4: Δ-7 · h=55 2021Q1: Δ+0 · h=55 2021Q2: Δ+7 · h=62 2021Q3: Δ+12 · h=74 2021Q4: Δ+22 · h=96 2022Q1: Δ+6 · h=102 2022Q2: Δ-12 · h=90 2022Q3: Δ-3 · h=87 2022Q4: Δ-7 · h=80 2023Q1: Δ+10 · h=90 2023Q2: Δ+23 · h=113 2023Q3: Δ+1 · h=114 2023Q4: Δ+4 · h=118 2024Q1: Δ+6 · h=124 2024Q2: Δ+11 · h=135 2024Q3: Δ+6 · h=141 2024Q4: Δ+24 · h=165 2025Q1: Δ+2 · h=167 2025Q2: Δ-6 · h=161 2025Q3: Δ+21 · h=182 2025Q4: Δ+33 · h=215 2026Q1: Δ+10 · h=225 2018Q1: holders=36 2018Q2: holders=51 2018Q3: holders=70 2018Q4: holders=67 2019Q1: holders=64 2019Q2: holders=55 2019Q3: holders=60 2019Q4: holders=65 2020Q1: holders=70 2020Q2: holders=65 2020Q3: holders=62 2020Q4: holders=55 2021Q1: holders=55 2021Q2: holders=62 2021Q3: holders=74 2021Q4: holders=96 2022Q1: holders=102 2022Q2: holders=90 2022Q3: holders=87 2022Q4: holders=80 2023Q1: holders=90 2023Q2: holders=113 2023Q3: holders=114 2023Q4: holders=118 2024Q1: holders=124 2024Q2: holders=135 2024Q3: holders=141 2024Q4: holders=165 2025Q1: holders=167 2025Q2: holders=161 2025Q3: holders=182 2025Q4: holders=215 2026Q1: holders=225 -33 -16.5 +0 +16.5 +33 32135237 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 8 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 16% -11.7%
2025Q3 Top 15% +18.7% +6.8%
2023Q2 Top 9% -11.2% -2.5%
2023Q1 Top 16% +6.1% -6.8%
2021Q3 Top 15% +26.1% -20.5%
2020Q1 Top 15%
2018Q3 Top 11%
2018Q2 Top 16%

Options Sentiment

Put holders
2
QoQ: +2
Call holders
2
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
51.2
EPS (TTM)
$1.83
EPS YoY
+18.1%
Revenue (TTM)
$0.1B
Revenue YoY
+14.8%
Quarterly Revenue & EPS (4Y)
2022-06-30: $13M 2022-09-30: $13M 2022-12-31: $15M 2023-03-31: $15M 2023-06-30: $16M 2023-09-30: $17M 2023-12-31: $17M 2024-03-31: $18M 2024-06-30: $18M 2024-09-30: $18M 2024-12-31: $19M 2025-03-31: $20M 2025-06-30: $20M 2025-09-30: $21M 2025-12-31: $23M 2026-03-31: $22M 2022-06-30: EPS 0.26 2022-09-30: EPS 0.27 2022-12-31: EPS 0.29 2023-03-31: EPS 0.27 2023-06-30: EPS 0.33 2023-09-30: EPS 0.40 2023-12-31: EPS 0.35 2024-03-31: EPS 0.32 2024-06-30: EPS 0.38 2024-09-30: EPS 0.40 2024-12-31: EPS 0.40 2025-03-31: EPS 0.37 2025-06-30: EPS 0.45 2025-09-30: EPS 0.43 2025-12-31: EPS 0.50 2026-03-31: EPS 0.45 0M 11M 23M $M 0.00 0.28 0.55 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 36 2023-03-31: PE 40.32023-06-30: PE 40.12023-09-30: PE 31.42023-12-31: PE 32.72024-03-31: PE 29.22024-06-30: PE 302024-09-30: PE 35.12024-12-31: PE 36.12025-03-31: PE 34.22025-06-30: PE 42.82025-09-30: PE 50.62025-12-31: PE 56.82026-03-31: PE 47.2 26 43 60 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)